Cargando…
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581631/ https://www.ncbi.nlm.nih.gov/pubmed/37561981 http://dx.doi.org/10.1200/PO.22.00594 |
_version_ | 1785122177765343232 |
---|---|
author | Pappas, Leontios Baiev, Islam Reyes, Stephanie Bocobo, Andrea Grace Jain, Apurva Spencer, Kristen Le, Tri Minh Rahma, Osama E. Maurer, Jordan Stanton, Jen Zhang, Karen De Armas, Anaemy Danner Deleon, Thomas T. Roth, Marc Peters, Mary Linton B. Zhu, Andrew X. Boyhen, Kylie VanCott, Christine Patel, Tushar Roberts, Lewis R. Lindsey, Stacie Horick, Nora Lennerz, Jochen K. Iafrate, A. John Goff, Laura Williams Mody, Kabir Borad, Mitesh J. Shroff, Rachna T. Javle, Milind M. Kelley, R. Katie Goyal, Lipika |
author_facet | Pappas, Leontios Baiev, Islam Reyes, Stephanie Bocobo, Andrea Grace Jain, Apurva Spencer, Kristen Le, Tri Minh Rahma, Osama E. Maurer, Jordan Stanton, Jen Zhang, Karen De Armas, Anaemy Danner Deleon, Thomas T. Roth, Marc Peters, Mary Linton B. Zhu, Andrew X. Boyhen, Kylie VanCott, Christine Patel, Tushar Roberts, Lewis R. Lindsey, Stacie Horick, Nora Lennerz, Jochen K. Iafrate, A. John Goff, Laura Williams Mody, Kabir Borad, Mitesh J. Shroff, Rachna T. Javle, Milind M. Kelley, R. Katie Goyal, Lipika |
author_sort | Pappas, Leontios |
collection | PubMed |
description | PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study to date on AYA disease biology, treatment patterns, and survival outcomes in CCA. METHODS: A multi-institutional cohort of patients with CCA diagnosed with intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC) was used for analysis. Retrospective chart review was conducted on patients who were 50 years old and younger (young; n = 124) and older than 50 years (older; n = 723). RESULTS: Among 1,039 patients screened, 847 patients met eligibility (72% ICC, 28% ECC). Young patients had a larger median tumor size at resection compared with older patients (4.2 v 3.6 cm; P = .048), more commonly had N1 disease (65% v 43%; P = .040), and were more likely to receive adjuvant therapy (odds ratio, 4.0; 95% CI, 1.64 to 9.74). Tumors of young patients were more likely to harbor an FGFR2 fusion, BRAF mutation, or ATM mutation (P < .05 for each). Young patients were more likely to receive palliative systemic therapy (96% v 69%; P < .001), targeted therapy (23% v 8%; P < .001), and treatment on a clinical trial (31% v 19%; P = .004). Among patients who presented with advanced disease, young patients had a higher median overall survival compared with their older counterparts (17.7 v 13.5 months; 95% CI, 12.6 to 22.6 v 11.4 to 14.8; P = .049). CONCLUSION: Young patients with CCA had more advanced disease at resection, more commonly received both adjuvant and palliative therapies, and demonstrated improved survival compared with older patients. Given the low clinical trial enrollment and poor outcomes among some AYA cancer populations, data to the contrary in CCA are highly encouraging. |
format | Online Article Text |
id | pubmed-10581631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-105816312023-10-18 The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma Pappas, Leontios Baiev, Islam Reyes, Stephanie Bocobo, Andrea Grace Jain, Apurva Spencer, Kristen Le, Tri Minh Rahma, Osama E. Maurer, Jordan Stanton, Jen Zhang, Karen De Armas, Anaemy Danner Deleon, Thomas T. Roth, Marc Peters, Mary Linton B. Zhu, Andrew X. Boyhen, Kylie VanCott, Christine Patel, Tushar Roberts, Lewis R. Lindsey, Stacie Horick, Nora Lennerz, Jochen K. Iafrate, A. John Goff, Laura Williams Mody, Kabir Borad, Mitesh J. Shroff, Rachna T. Javle, Milind M. Kelley, R. Katie Goyal, Lipika JCO Precis Oncol ORIGINAL REPORTS PURPOSE: Increased awareness of the distinct tumor biology for adolescents and young adults (AYAs) with cancer has led to improvement in outcomes for this population. However, in cholangiocarcinoma (CCA), a paucity of data exist on the AYA population. To our knowledge, we present the largest study to date on AYA disease biology, treatment patterns, and survival outcomes in CCA. METHODS: A multi-institutional cohort of patients with CCA diagnosed with intrahepatic cholangiocarcinoma (ICC) or extrahepatic cholangiocarcinoma (ECC) was used for analysis. Retrospective chart review was conducted on patients who were 50 years old and younger (young; n = 124) and older than 50 years (older; n = 723). RESULTS: Among 1,039 patients screened, 847 patients met eligibility (72% ICC, 28% ECC). Young patients had a larger median tumor size at resection compared with older patients (4.2 v 3.6 cm; P = .048), more commonly had N1 disease (65% v 43%; P = .040), and were more likely to receive adjuvant therapy (odds ratio, 4.0; 95% CI, 1.64 to 9.74). Tumors of young patients were more likely to harbor an FGFR2 fusion, BRAF mutation, or ATM mutation (P < .05 for each). Young patients were more likely to receive palliative systemic therapy (96% v 69%; P < .001), targeted therapy (23% v 8%; P < .001), and treatment on a clinical trial (31% v 19%; P = .004). Among patients who presented with advanced disease, young patients had a higher median overall survival compared with their older counterparts (17.7 v 13.5 months; 95% CI, 12.6 to 22.6 v 11.4 to 14.8; P = .049). CONCLUSION: Young patients with CCA had more advanced disease at resection, more commonly received both adjuvant and palliative therapies, and demonstrated improved survival compared with older patients. Given the low clinical trial enrollment and poor outcomes among some AYA cancer populations, data to the contrary in CCA are highly encouraging. Wolters Kluwer Health 2023-08-10 /pmc/articles/PMC10581631/ /pubmed/37561981 http://dx.doi.org/10.1200/PO.22.00594 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | ORIGINAL REPORTS Pappas, Leontios Baiev, Islam Reyes, Stephanie Bocobo, Andrea Grace Jain, Apurva Spencer, Kristen Le, Tri Minh Rahma, Osama E. Maurer, Jordan Stanton, Jen Zhang, Karen De Armas, Anaemy Danner Deleon, Thomas T. Roth, Marc Peters, Mary Linton B. Zhu, Andrew X. Boyhen, Kylie VanCott, Christine Patel, Tushar Roberts, Lewis R. Lindsey, Stacie Horick, Nora Lennerz, Jochen K. Iafrate, A. John Goff, Laura Williams Mody, Kabir Borad, Mitesh J. Shroff, Rachna T. Javle, Milind M. Kelley, R. Katie Goyal, Lipika The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title_full | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title_fullStr | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title_full_unstemmed | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title_short | The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma |
title_sort | cholangiocarcinoma in the young (city) study: tumor biology, treatment patterns, and survival outcomes in adolescent young adults with cholangiocarcinoma |
topic | ORIGINAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581631/ https://www.ncbi.nlm.nih.gov/pubmed/37561981 http://dx.doi.org/10.1200/PO.22.00594 |
work_keys_str_mv | AT pappasleontios thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT baievislam thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT reyesstephanie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT bocoboandreagrace thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT jainapurva thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT spencerkristen thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT letriminh thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT rahmaosamae thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT maurerjordan thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT stantonjen thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT zhangkaren thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT dearmasanaemydanner thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT deleonthomast thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT rothmarc thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT petersmarylintonb thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT zhuandrewx thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT boyhenkylie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT vancottchristine thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT pateltushar thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT robertslewisr thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT lindseystacie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT horicknora thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT lennerzjochenk thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT iafrateajohn thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT gofflaurawilliams thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT modykabir thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT boradmiteshj thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT shroffrachnat thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT javlemilindm thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT kelleyrkatie thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT goyallipika thecholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT pappasleontios cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT baievislam cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT reyesstephanie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT bocoboandreagrace cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT jainapurva cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT spencerkristen cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT letriminh cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT rahmaosamae cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT maurerjordan cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT stantonjen cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT zhangkaren cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT dearmasanaemydanner cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT deleonthomast cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT rothmarc cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT petersmarylintonb cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT zhuandrewx cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT boyhenkylie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT vancottchristine cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT pateltushar cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT robertslewisr cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT lindseystacie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT horicknora cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT lennerzjochenk cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT iafrateajohn cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT gofflaurawilliams cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT modykabir cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT boradmiteshj cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT shroffrachnat cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT javlemilindm cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT kelleyrkatie cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma AT goyallipika cholangiocarcinomaintheyoungcitystudytumorbiologytreatmentpatternsandsurvivaloutcomesinadolescentyoungadultswithcholangiocarcinoma |